Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125442 | SCV000168894 | benign | not specified | 2014-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000204708 | SCV000259781 | benign | Hypertrophic cardiomyopathy | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000125442 | SCV000269185 | benign | not specified | 2015-04-01 | criteria provided, single submitter | clinical testing | c.380-9C>G in intron 1 of JPH2: This variant is not expected to have clinical si gnificance because it has been identified in 2.9% (78/2666) of Finnish chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs111987307). |
ARUP Laboratories, |
RCV001727584 | SCV001473043 | benign | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000613922 | SCV000734075 | likely benign | Hypertrophic cardiomyopathy 17 | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000125442 | SCV001925635 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000125442 | SCV001958341 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727584 | SCV001969030 | likely benign | not provided | no assertion criteria provided | clinical testing |